ProductLife Group

Last week, Xavier Duburcq, CEO, and Thomas Galvain, Head of Corporate Development, received on behalf of ProductLife Group, the Award of the best Buy & Build strategy from Leaders League. During the last round of the 23th Private Equity Exchange challenge, the jury recognized the value of PLG’s acquisition strategy and how it has supported the growth of the Group during the last 4 years, transforming it from a regional player into a global leader of 2,000 experts, supporting patient access to innovative, safe and effective medical solutions. This comes as a recognition for the hard work of our teams as well as the loyalty of our clients in supporting such growth. Follow our success story on https://lnkd.in/dhCZTE-m #PEX #Growth #ClientSuccess #GlobalReach #TeamSuccess

📣 Register to our webinar: Drug Device Combinations in the EU & Article 117 👉 Register here: https://lnkd.in/ehY3ZBTY 📅 November 26, 3PM CET Are you planning to submit your Drug Device combination as a medicinal product in the EU? How to address the Medical Device part? What is Article 117 of the Medical Device Regulation and how to use it? Eline Dirven and Tom Manussen will guide through the most important aspects to support you with a successful registration of your Drug Device combination. Save your spot now to our monthly Zwiers Regulatory Consultancy BV, a ProductLife Group company, webinar: #pharma #drug #medicaldevice #drugdevice #healthcare #webinar #lifescience #regulatory #compliance

📣 2 more days until European Pharmacovigilance Congress in Milan Italy. As a global company with firm established expertise in the local market of Italy, ProductLife is thrilled to be participating to the event which is recognized as one of the most appreciated global pharmacovigilance conferences, offering a unique opportunity to enhance your professional skills and connect with internationally renowned experts. → Interested in meeting in person?     📲 Connect now to secure meeting with our team: Andrea Pieri, Hélène Masset, Mario Rizzitano, LORENZO BACCI   OR    📍 Drop by the ProductLife and Pharma D&S table to say hello.   We look forward to seeing you there!

💊 Continuous Manufacturing (CM) is revolutionizing how we produce drugs. With ICH Q13 providing a regulatory framework, companies can transition from batch manufacturing to a more efficient and flexible CM process. From boosting productivity to improving product quality, CM holds immense potential for new drugs, generics, and biosimilars. However, navigating regulatory frameworks like ICH Q13 can be challenging. Dive deeper into the regulatory side of CM with the first part of this interview with our expert, Jimmy Gandhi, CMC Specialist at ProductLife Group, who supports one of our biggest clients! 👉 Read more here: https://lnkd.in/emxpn7br 👀 Find out about our services here: https://lnkd.in/eBSRarVE #pharmaceuticals #cmc #continuousmanufacturing #regulatoryaffairs #ichq13

🎉 Day 2 at ISPOR Europe 2024 is in full energy! We’re having an incredible time connecting with experts, sharing insights, and exploring innovative solutions for healthcare access and outcomes. 🌍 📍 Visit us at Booth 713! Meet the ProductLife Group and our specialized Market & Patient Access entities—Intexo Società Benefit (A ProductLife Group Company), Commercial Eyes Pty Ltd, and Outcomes'10—to discuss how we can support your market and patient access needs. 💡 Don’t miss the chance to explore our 12 research posters and learn about: ✅ PICO evaluations ✅ Access pathways for innovative medicines ✅ Real-world data insights ✅ Environmental impacts in healthcare…and much more! 🤝 Let’s collaborate to create impactful healthcare solutions. Stop by Booth 713 or message our team members to schedule a meeting today with Mariangela Prada, Jo Atkins, Almudena Del Castillo Saiz, Annie Jullien Pannelay, Luis Lizán, Francisco Javier Pérez Sádaba, Letizia Rossi, Elisa Elena Mariano, Giulia Fagnocchi, Alessia Marocco, Asís Ariznavarreta and Neus Vidal #ISPOREurope2024 #HealthcareInnovation #MarketAccess #PatientAccess #RealWorldEvidence #Collaboration

📣 Register to our webinar: Drug Device Combinations in the EU & Article 117 👉 Register here: https://lnkd.in/ehY3ZBTY 📅 November 26, 3PM CET Are you planning to submit your Drug Device combination as a medicinal product in the EU? How to address the Medical Device part? What is Article 117 of the Medical Device Regulation and how to use it? Eline Dirven and Tom Manussen will guide through the most important aspects to support you with a successful registration of your Drug Device combination. Save your spot now to our monthly Zwiers Regulatory Consultancy BV, a ProductLife Group company, webinar: #pharma #drug #medicaldevice #drugdevice #healthcare #webinar #lifescience #regulatory #compliance

🌟Recap from MEDICA 2024! We’re thrilled to have been part of this year’s MEDICA in Düsseldorf! A huge thank you to everyone who joined us at the German Pavilion for our sessions led by Aymeric Lebon, our Medtech Commercial Director. 🙌 Key Takeaways: 1️⃣ Regulatory Strategy for IVDR Transition: Attendees gained practical insights into developing effective strategies for IVDR compliance, ensuring seamless market transitions while aligning with business goals. 2️⃣ AI in Medical Software Validation: We explored the challenges and opportunities in clinically validating AI-driven software, from leveraging the European AI Act to optimizing costs with augmented data strategies. Our team had amazing conversations with Medtech professionals from all over the world and are looking forward to support your business journey. 🔗 Contact us here: https://lnkd.in/eF9aT9dy #Medica2024 #Medtech #IVDR #Innovation

La gestion des pénuries de dispositifs médicaux, un sujet d'actualité décrypté par nos experts le 19 Novembre. Plus que 3 jours pour vous inscrire:

📣 2 more days until ISPOR EUROPE 2024! 📍 Visit booth 713 to meet with ProductLife Group and our entities specialized in Market and Patient Access - Intexo Società Benefit (A ProductLife Group Company) , Commercial Eyes Pty Ltd and Outcomes'10 📲 Connect now to secure meetings to discuss your unique business needs with: Mariangela Prada, Jo Atkins, Almudena Del Castillo Saiz, Annie Jullien Pannelay, Luis Lizán, Francisco Javier Pérez Sádaba, Letizia Rossi, Elisa Elena Mariano, Giulia Fagnocchi, Alessia Marocco, CLAUDIA BERTOZZI Asís Ariznavarreta and Neus Vidal 💡 Want to learn more about our real life projects? Visit our on-site collection of 12 research posters including:  ·       PICO Evaluation Differences across Australia, EU4, and the UK ·       Treatment Availability for ATMPs: Comparing regulatory and market access decisions across regions ·       Early Access Pathways for innovative medicines in Australia, EU4, and the UK ·       Real-World Data and Evidence in Australia, EU4, and the UK ·       Italy’s New Scientific and Economic Committee: Initial assessments and activities ·       Value Contribution of Trifluridine/Tipiracil with Bevacizumab for metastatic colorectal cancer in Catalonia ·       Environmental Impact of Inhalers for asthma and COPD in Spain ·       Onco-Hematology Drug Access: Current barriers and strategies ·       Humanistic and Economic Impact of Lysosomal Storage Disorders in Spain ·       Cost-Effectiveness of Dostarlimab Monotherapy for advanced endometrial cancer (Finalist - TP 5%) ·       Cost-Effectiveness of Nirmatrelvir/Ritonavir in high-risk COVID-19 patients in Spain ·       Cost-Effectiveness of Abrocitinib vs. Dupilumab for severe atopic dermatitis in adolescents in Spain See you soon in Barcelona!

D-4 [Free Webinar in French 💻] 🆕 Gestion des pénuries de dispositifs médicaux : un enjeu de santé publique à relever pour les opérateurs économiques. La disponibilité des DM et DMDIV est cruciale pour garantir la continuité des soins auprès des patients. 👉 Inscription ici: https://lnkd.in/erdu83M7 Industriels, de nouvelles obligations réglementaires vous imposent désormais de mettre en place des mesures de prévention des risques de rupture. Fabricant, Importateur ou Distributeur de Dispositifs Médicaux, vous êtes concernés par ces évolutions réglementaires ! Ne manquez pas notre webinaire le mardi 19 novembre de 11h30 à 12h30 pour un décryptage complet (inscription gratuite)! 🔔 Pascale Cousin et Blandine Thébault seront là pour répondre à vos questions et vous offrir des conseils d’expert. 👉 Inscription ici: https://lnkd.in/erdu83M7 STRATEGIQUAL SAS ProductLife Group #DM #DMDIV #santé #gestionpénurie #ANSM #webinaire #pharma #dispositifsmedicaux #medtech